110 related articles for article (PubMed ID: 37635485)
1. Stomatin-like protein-2 contributes the migration and invasion of breast cancer cells via regulating ERK/FOXO3a signaling pathway.
Wu S; Zhao L; Li Q
Chin J Physiol; 2023; 66(4):257-265. PubMed ID: 37635485
[TBL] [Abstract][Full Text] [Related]
2. Enhanced SLP-2 promotes invasion and metastasis by regulating Wnt/β-catenin signal pathway in colorectal cancer and predicts poor prognosis.
Zhou C; Li Y; Wang G; Niu W; Zhang J; Wang G; Zhao Q; Fan L
Pathol Res Pract; 2019 Jan; 215(1):57-67. PubMed ID: 30389319
[TBL] [Abstract][Full Text] [Related]
3. Stomatin-like protein 2 inhibits cisplatin-induced apoptosis through MEK/ERK signaling and the mitochondrial apoptosis pathway in cervical cancer cells.
Hu G; Zhang J; Xu F; Deng H; Zhang W; Kang S; Liang W
Cancer Sci; 2018 May; 109(5):1357-1368. PubMed ID: 29516570
[TBL] [Abstract][Full Text] [Related]
4. SLP-2 regulates the generation of reactive oxygen species and the ERK pathway to promote papillary thyroid carcinoma motility and angiogenesis.
Chen J; Wang D; Xu R; Yao T; Guo Y; Liu Q; Yang E; Wu Z; Xu Z
Tissue Cell; 2023 Feb; 80():101997. PubMed ID: 36527788
[TBL] [Abstract][Full Text] [Related]
5. ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.
Xie Y; Gou Q; Xie K; Wang Z; Wang Y; Zheng H
Oncotarget; 2016 Sep; 7(38):61273-61283. PubMed ID: 27542224
[TBL] [Abstract][Full Text] [Related]
6. Stomatin-like protein 2 is associated with the clinicopathological features of human papillary thyroid cancer and is regulated by TGF-β in thyroid cancer cells.
Liu Z; Yang Y; Zhang Y; Ye X; Wang L; Xu G
Oncol Rep; 2014 Jan; 31(1):153-60. PubMed ID: 24190591
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of SLP-2 in epithelial ovarian cancer and its regulatory effect on the Notch signaling pathway.
Guo XY; Guo HF; Guo HM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1666-1671. PubMed ID: 32141532
[TBL] [Abstract][Full Text] [Related]
8. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.
Bartolome A; Boskovic S; Paunovic I; Bozic V; Cvejic D
APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues.
Wang Y; Morrow JS
J Biol Chem; 2000 Mar; 275(11):8062-71. PubMed ID: 10713127
[TBL] [Abstract][Full Text] [Related]
10. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
[TBL] [Abstract][Full Text] [Related]
11. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.
Zhang L; Ding F; Cao W; Liu Z; Liu W; Yu Z; Wu Y; Li W; Li Y; Liu Z
Clin Cancer Res; 2006 Mar; 12(5):1639-46. PubMed ID: 16533792
[TBL] [Abstract][Full Text] [Related]
12. Expression of SLP-2 was associated with invasion of esophageal squamous cell carcinoma.
Cao W; Zhang B; Ding F; Zhang W; Sun B; Liu Z
PLoS One; 2013; 8(5):e63890. PubMed ID: 23667687
[TBL] [Abstract][Full Text] [Related]
13. Stomatin-like protein 2 regulates survivin expression in non-small cell lung cancer cells through β-catenin signaling pathway.
Yang CT; Li JM; Li LF; Ko YS; Chen JT
Cell Death Dis; 2018 Apr; 9(4):425. PubMed ID: 29556045
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
15. The regulatory role of SLP-2 and mechanism on CCBE1 gene expression in rectal carcinoma and adjacent lymphatic tube tissues.
Guo RL; Wang XR; Wang QG; Li Z; Lu X; Miao RZ; Chang H
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):87-94. PubMed ID: 29364474
[TBL] [Abstract][Full Text] [Related]
16. miR‑302d‑3p regulates the viability, migration and apoptosis of breast cancer cells through regulating the TMBIM6‑mediated ERK signaling pathway.
Liao Y; Qiu Z; Bai L
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651659
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between SLP-2 expression and prognosis in laryngeal squamous cell carcinoma and mammary invasive carcinoma].
Cao WF; Zhang LY; Zhang B; Liu MB; Liu ZH; Sun BC
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):332-7. PubMed ID: 20654157
[TBL] [Abstract][Full Text] [Related]
18. [Effect of stomatin-like protein 2 (SLP-2) gene on growth and proliferation of esophageal squamous carcinoma cell line TE12].
Zhang LY; Ding F; Liu ZM; Li WD; Liu ZH; Li YD
Ai Zheng; 2005 Feb; 24(2):155-9. PubMed ID: 15694024
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of myosin VI contributes to breast cancer progression via MAPK/ERK signaling pathway.
Zhan XJ; Wang R; Kuang XR; Zhou JY; Hu XL
Cell Signal; 2023 Jun; 106():110633. PubMed ID: 36803774
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of SLP-2 correlate with poor prognosis in gastric cancer.
Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
Gastric Cancer; 2013 Oct; 16(4):498-504. PubMed ID: 23371255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
